Seed 2 Growth Ventures (S2G), a Chicago-based company, has led an investment in Vancouver-based Terramera Inc. Both companies are aligned in their focus to support sustainable agriculture while increasing farm yields. Other key investors in the financing include ACA Investments (affiliate of Sumitomo Corporation), Bold Capital Partners, Renewal Funds and Maumee Ventures._x000D_
_x000D_
“Terramera is very proud to be working with S2G Ventures as our lead investor in this recent round of financing,” said Terramera CEO, Karn Manhas. “Terramera develops safer, more effective solutions for public health, sustainable food production, and bee health, by harnessing the power of natural plant defenses with innovative green chemistry. This investment allows us to continue our rapid growth, fund products to get to market, and support Terramera’s advancement as a sustainable technology leader.”_x000D_
_x000D_
By studying plants that have evolved highly-effective defenses against pests and disease, Terramera has developed proprietary platforms that stabilize and deliver complex plant biochemicals, such as cold-pressed neem and other plant-extracts (Neem is a tropical evergreen tree native to South Asia. Neem extracts have been used in human health care, hair, skin and dental care, traditional medicine and environmental uses for thousands of years). Terramera’s Inspirium Technology increases the efficiency and performance of biological materials, allowing them to perform more efficiently, according to the company._x000D_
_x000D_
Terramera’s consumer line, Proof, includes the only EPA-registered products that are 100% effective against bed bugs and their eggs. Terramera’s agricultural products, under development, increase sustainability and profitability of conventional farms, and can help farmers profitably transition to organic, the company says._x000D_
_x000D_
“Biopesticides and biofertilizers, which currently represent a small but growing part of the agriculture inputs market, are the next frontier for sustainable agriculture. One of the key issues holding back quicker adoption has been performance. Terramera has developed a technology that solves that, allowing current biologics to perform more effectively,” said Sanjeev Krishnan, Managing Director, S2G Ventures. “Terramera is uniquely positioned to lead the market with technology and products that are natural, highly-effective and most importantly, more economically beneficial to farmers. S2G Ventures is excited to partner with Terramera and help them scale. It’s a natural fit.”
